← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2023-1:813 | 813 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Epinephrine | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:813 | 813 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:813 | 813 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-6010 | 72682-6010-1 | Lysine Hydrochloride; Arginine Hydrochloride; Proline; Glutamine | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:813 | 813 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-115 | 69852-115-10 | Methylprednisolone Acetate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:813 | 813 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-401 | 73702-401-01 | Midazolam | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:813 | 813 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-517 | 70092-517-43 | Morphine Sulfate | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:813 | 813 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72907-2467 | 72907-2467-1 | Morphine Sulfate | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:814 | 814 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-159 | 73177-159-03 | Rocuronium Bromide | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:814 | 814 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estradiol; Progesterone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:814 | 814 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-068 | 71449-068-11 | Ketamine | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:814 | 814 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-982 | 69374-982-10 | Ketamine Hydrochloride | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:814 | 814 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0006 | 81483-0006-0 | Ketamine Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:814 | 814 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:814 | 814 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydroquinone; Fluocinolone Acetonide; Tretinoin | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:814 | 814 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-988 | 69374-988-10 | Lysine Hydrochloride; Arginine Hydrochloride | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:814 | 814 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:814 | 814 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-6290 | 71266-6290-1 | Lidocaine Hydrochloride; Epinephrine Bitartrate; Tetracaine Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:814 | 814 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:814 | 814 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-9415 | 72682-9415-1 | Lysine Hydrochloride; Arginine Hydrochloride; Proline; Glutamine | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:814 | 814 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-106 | 73177-106-05 | Midazolam | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:814 | 814 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9190 | 71266-9190-6 | Midazolam | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:814 | 814 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-132 | 70092-132-43 | Morphine Sulfate | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:814 | 814 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-097 | 71449-097-42 | Moxifloxacin Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:815 | 815 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-047 | 71506-047-10 | Phenylephrine Hydrochloride | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:815 | 815 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estradiol; Progesterone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:815 | 815 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-433 | 70004-433-05 | Ketamine Hydrochloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:815 | 815 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-982 | 69374-982-55 | Ketamine Hydrochloride | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:815 | 815 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:815 | 815 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-234 | 68985-234-91 | Hydromorphone Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:815 | 815 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydroquinone; Hydrocortisone; Tretinoin | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:815 | 815 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Magnesium Chloride | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:815 | 815 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:815 | 815 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Epinephrine Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:815 | 815 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:815 | 815 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Magnesium Chloride | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:815 | 815 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-106 | 73177-106-04 | Midazolam | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:815 | 815 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5030 | 71266-5030-2 | Midazolam | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:815 | 815 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1036 | 73013-1036-1 | Morphine Sulfate | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:815 | 815 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-089 | 71449-089-42 | Moxifloxacin Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:816 | 816 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-375 | 73693-375-01 | ESTRADIOL 6MG | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:816 | 816 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estradiol; Progesterone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:816 | 816 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:816 | 816 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:816 | 816 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-3022 | 71286-3022-1 | Ketamine Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:816 | 816 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70214-3011 | 70214-3011-1 | Hydromorphone Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:816 | 816 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydroquinone; Hydrocortisone; Tretinoin; Ascorbic Acid | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:816 | 816 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2431 | 72627-2431-1 | Magnesium Chloride Tetrahydrate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:816 | 816 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:816 | 816 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Oxymetazoline Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:816 | 816 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:816 | 816 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Magnesium Chloride | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:816 | 816 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5030 | 71266-5030-1 | Midazolam | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:816 | 816 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5030 | 71266-5030-1 | Midazolam | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:816 | 816 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-156 | 82396-156-25 | Morphine Sulfate | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:816 | 816 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8613 | 71266-8613-1 | Moxifloxacin Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:817 | 817 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6518 | 72934-6518-2 | Melidu | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:817 | 817 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:817 | 817 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9070 | 71266-9070-2 | Ketamine Hydrochloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:817 | 817 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:817 | 817 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-521 | 69374-521-31 | Ketamine Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:817 | 817 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:817 | 817 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydroquinone; Hydrocortisone; Tretinoin; Ascorbic Acid | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:817 | 817 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0217 | 72196-0217-1 | Magnesium Chloride; Dextrose Monohydrate; Lidocaine Hydrochloride; Sodium Bicarbonate; Calcium Chloride; Sodium Chloride; Sodium Gluconate; Sodium Acetate; Potassium Chloride | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:817 | 817 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:817 | 817 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Oxymetazoline Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:817 | 817 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:817 | 817 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5105 | 26436-5105-5 | Magnesium Chloride | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:817 | 817 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5030 | 71266-5030-2 | Midazolam | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:817 | 817 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-130 | 71449-130-32 | Midazolam Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:817 | 817 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:817 | 817 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-096 | 71449-096-42 | Moxifloxacin Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:818 | 818 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-692 | 70092-692-44 | Sodium Citrate PF 4% 3 ml-5 ml syr | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:818 | 818 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:818 | 818 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9070 | 71266-9070-1 | Ketamine Hydrochloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:818 | 818 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:818 | 818 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-521 | 69374-521-20 | Ketamine Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:818 | 818 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:818 | 818 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydroquinone; Tretinoin; Dexamethasone | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:818 | 818 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Magnesium Chloride; Zinc Sulfate; Copper Gluconate; Sodium Selenite; Manganese Sulfate | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:818 | 818 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:818 | 818 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Phenylephrine Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:818 | 818 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:818 | 818 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Magnesium Chloride; Zinc Sulfate Heptahydrate; Copper Gluconate; Manganese Sulfate | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:818 | 818 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9190 | 71266-9190-6 | Midazolam | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:818 | 818 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-418 | 70092-418-36 | Midazolam Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:818 | 818 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:818 | 818 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:819 | 819 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6176 | 72196-6176-1 | Vancomycin 1.5gm added to NS | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:819 | 819 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:819 | 819 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:819 | 819 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-069 | 71449-069-11 | Ketamine Hydrochloride | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:819 | 819 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-430 | 70004-430-12 | Ketamine Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:819 | 819 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydroxocobalamin | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:819 | 819 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2434 | 72627-2434-2 | Hydroxocobalamin | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:819 | 819 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6147 | 72196-6147-1 | Magnesium Sulfate Heptahydrate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:819 | 819 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-3102 | 72627-3102-1 | Lidocaine; Tetracaine | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:819 | 819 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-090 | 71449-090-42 | Lidocaine Hydrochloride; Phenylephrine Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:819 | 819 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9100 | 71266-9100-3 | Lidocaine Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:819 | 819 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Magnesium Sulfate Heptahydrate | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:819 | 819 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:819 | 819 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:819 | 819 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-522 | 70092-522-35 | Morphine Sulfate | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:819 | 819 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-129 | 69194-129-01 | Moxifloxacin Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:820 | 820 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-293 | 70092-293-49 | Hydromorph PF1 mg/ml 30ml NS-35 ml MB | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:820 | 820 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:820 | 820 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:820 | 820 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:820 | 820 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-430 | 70004-430-09 | Ketamine Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:820 | 820 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2434 | 72627-2434-2 | Hydroxocobalamin | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:820 | 820 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydroxychloroquine Sulfate | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:820 | 820 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6148 | 72196-6148-1 | Magnesium Sulfate Heptahydrate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:820 | 820 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1006 | 73271-1006-1 | Lidocaine; Tetracaine; Benzocaine | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:820 | 820 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-147 | 70092-147-03 | Lidocaine Hydrochloride; Potassium Chloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:820 | 820 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9100 | 71266-9100-2 | Lidocaine Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:820 | 820 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0202 | 71285-0202-1 | Mannitol; Lidocaine Hydrochloride; Magnesium Sulfate Heptahydrate; Magnesium Chloride; Sodium Gluconate; Sodium Acetate; Potassium Chloride; Sodium Chloride; Sodium Bicarbonate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:820 | 820 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-418 | 70092-418-36 | Midazolam Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:820 | 820 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Miglustat | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:820 | 820 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:820 | 820 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9080 | 83826-9080-1 | Moxifloxacin Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:821 | 821 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-031 | 71506-031-51 | Phenylephrine Hydrochloride | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:821 | 821 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:821 | 821 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:821 | 821 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-521 | 69374-521-31 | Ketamine Hydrochloride | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:821 | 821 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:821 | 821 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydroxocobalamin; Folic Acid | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:821 | 821 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydroxyzine Pamoate | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:821 | 821 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6147 | 71285-6147-1 | Magnesium Sulfate Heptahydrate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:821 | 821 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-2588 | 72682-2588-4 | Lidocaine; Tetracaine; Benzocaine | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:821 | 821 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0211 | 71285-0211-1 | Lidocaine Hydrochloride; Sodium Bicarbonate; Sodium Acetate; Potassium Chloride; Magnesium Chloride; Sodium Chloride; Sodium Gluconate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:821 | 821 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:821 | 821 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0202 | 72196-0202-1 | Mannitol; Lidocaine Hydrochloride; Magnesium Sulfate Heptahydrate; Magnesium Chloride; Sodium Gluconate; Sodium Acetate; Potassium Chloride; Sodium Chloride; Sodium Bicarbonate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:821 | 821 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:821 | 821 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4604 | 72934-4604-8 | Minoxidil; Betamethasone Dipropionate | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:821 | 821 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:821 | 821 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9081 | 83826-9081-1 | Moxifloxacin Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:822 | 822 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-156 | 73177-156-02 | Ketamine Hydrochloride | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:822 | 822 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:822 | 822 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:822 | 822 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-521 | 69374-521-20 | Ketamine Hydrochloride | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:822 | 822 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-513 | 69374-513-50 | Ketamine Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:822 | 822 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydroxocobalamin; Levocarnitine; Succinylcholine Chloride; Methionine; Riboflavin 5'-Phosphate Sodium; Thiamine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:822 | 822 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Idoxuridine | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:822 | 822 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6148 | 71285-6148-1 | Magnesium Sulfate Heptahydrate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:822 | 822 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-077 | 73198-077-30 | Lysine | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:822 | 822 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0211 | 72196-0211-1 | Lidocaine Hydrochloride; Sodium Bicarbonate; Sodium Acetate; Potassium Chloride; Magnesium Chloride; Sodium Chloride; Sodium Gluconate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:822 | 822 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:822 | 822 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0205 | 71285-0205-1 | Mannitol; Lidocaine Hydrochloride; Sodium Bicarbonate; Sodium Chloride; Potassium Chloride; Calcium Chloride | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:822 | 822 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-177 | 70092-177-35 | Midazolam Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:822 | 822 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4610 | 72934-4610-8 | Minoxidil; Niacinamide | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:822 | 822 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-520 | 70092-520-49 | Morphine Sulfate | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:822 | 822 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-611 | 81375-611-01 | Moxifloxacin Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:823 | 823 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-140 | 73702-140-71 | Indomethacin | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:823 | 823 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:823 | 823 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-3022 | 71286-3022-1 | Ketamine Hydrochloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:823 | 823 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:823 | 823 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-511 | 69374-511-01 | Ketamine Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:823 | 823 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydroxocobalamin; Pyridoxine; Succinylcholine Chloride; Methionine; Inositol | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:823 | 823 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2418 | 72627-2418-1 | Inositol; Choline Chloride; Methionine | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:823 | 823 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6048 | 71285-6048-1 | Magnesium Sulfate Heptahydrate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:823 | 823 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0401 | 71285-0401-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:823 | 823 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Tetracaine Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:823 | 823 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-6006 | 71286-6006-1 | Lidocaine Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:823 | 823 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0111 | 71285-0111-1 | Mannitol; Magnesium Sulfate Heptahydrate; Sodium Chloride; Potassium Chloride; Magnesium Chloride; Tromethamine; Dextrose Monohydrate; Sodium Acetate; Sodium Gluconate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:823 | 823 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-130 | 71449-130-32 | Midazolam Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:823 | 823 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4609 | 72934-4609-8 | Minoxidil; Progesterone | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:823 | 823 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-611 | 81375-611-01 | Moxifloxacin Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:823 | 823 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-615 | 81375-615-01 | Moxifloxacin Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:824 | 824 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 54288-827 | 54288-827-25 | Semaglutide Injection, 5 mg/2 mL (2.5 mg/mL) | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:824 | 824 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:824 | 824 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-3020 | 71286-3020-1 | Ketamine Hydrochloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:824 | 824 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-433 | 70004-433-05 | Ketamine Hydrochloride | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:824 | 824 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-982 | 69374-982-55 | Ketamine Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:824 | 824 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5492 | 26436-5492-1 | Hydroxychloroquine Sulfate | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:824 | 824 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2419 | 72627-2419-1 | Inositol; Choline Chloride; Methionine; Cyanocobalamin | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:824 | 824 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8073 | 71285-8073-1 | Magnesium Sulfate Heptahydrate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:824 | 824 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0401 | 72196-0401-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:824 | 824 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Tetracaine Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:824 | 824 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-023 | 71449-023-11 | Lidocaine Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:824 | 824 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methadone Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:824 | 824 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83298-100 | 83298-100-30 | Miglustat | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:824 | 824 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4602 | 72934-4602-8 | Minoxidil; Tretinoin; Fluocinolone Acetonide | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:824 | 824 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-615 | 81375-615-01 | Moxifloxacin Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:824 | 824 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8604 | 71266-8604-1 | Moxifloxacin Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:825 | 825 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0407 | 71285-0407-1 | Trophamine 3.5% / Dextrose 10% With Calcium Gluconate 3.75 mEq 250ml in 250ml bag | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:825 | 825 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:825 | 825 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9080 | 71266-9080-1 | Ketamine Hydrochloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:825 | 825 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:825 | 825 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-982 | 69374-982-33 | Ketamine Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:825 | 825 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5370 | 26436-5370-3 | Hydroxyprogesterone Caproate | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:825 | 825 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79926-017 | 79926-017-05 | Insulin Glargine | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:825 | 825 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7080 | 71285-7080-1 | Magnesium Sulfate Heptahydrate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:825 | 825 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0415 | 72196-0415-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:825 | 825 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6622 | 71300-6622-5 | Lidocaine Hydrochloride; Tetracaine Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:825 | 825 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-520 | 69374-520-05 | Lidocaine Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:825 | 825 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-149 | 73177-149-02 | Methadone Hydrochloride | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:825 | 825 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4350 | 72934-4350-8 | Minoxidil; Betamethasone Dipropionate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:825 | 825 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-103 | 81375-103-40 | Mitomycin | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:825 | 825 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-096 | 71449-096-42 | Moxifloxacin Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:825 | 825 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:826 | 826 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-477 | 70092-477-44 | Ephedrine PF 10 mg/ml in 5 ml NS syr | 2024-2 | valid | 0 | 2026-09-18 |